A citation-based method for searching scientific literature

Si Eun Kim, Byungju Lee, Seongbeom Park, Soo Hyun Cho, Seung Joo Kim, Yeshin Kim, Hyemin Jang, Jee Hyang Jeong, Soo Jin Yoon, Kyung Won Park, Eun-Joo Kim, Na Yeon Jung, Bora Yoon, Jae-Won Jang, Jin Yong Hong, Jihye Hwang, Duk L Na, Sang Won Seo, Seong Hye Choi, Hee Jin Kim. Alzheimers Res Ther 2020
Times Cited: 7







List of co-cited articles
26 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William Jagust, Oskar Hansson. Nat Commun 2017
372
57

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults.
Michelle E Farrell, Xi Chen, Melissa M Rundle, Micaela Y Chan, Gagan S Wig, Denise C Park. Neurology 2018
60
57

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
57

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
Osama Sabri, Marwan N Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao,[...]. Alzheimers Dement 2015
290
42

In vivo staging of regional amyloid deposition.
Michel J Grothe, Henryk Barthel, Jorge Sepulcre, Martin Dyrba, Osama Sabri, Stefan J Teipel. Neurology 2017
204
42

Amyloid involvement in subcortical regions predicts cognitive decline.
Soo Hyun Cho, Jeong-Hyeon Shin, Hyemin Jang, Seongbeom Park, Hee Jin Kim, Si Eun Kim, Seung Joo Kim, Yeshin Kim, Jin San Lee, Duk L Na,[...]. Eur J Nucl Med Mol Imaging 2018
25
42

Phases of A beta-deposition in the human brain and its relevance for the development of AD.
Dietmar R Thal, Udo Rüb, Mario Orantes, Heiko Braak. Neurology 2002
42

Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients.
Hyun-Jung Ahn, Juhee Chin, Aram Park, Byung Hwa Lee, Mee Kyung Suh, Sang Won Seo, Duk L Na. J Korean Med Sci 2010
281
42

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.
Sung Hoon Kang, Yu Hyun Park, Daun Lee, Jun Pyo Kim, Juhee Chin, Yisuh Ahn, Seong Beom Park, Hee Jin Kim, Hyemin Jang, Young Hee Jung,[...]. Dement Neurocogn Disord 2019
64
42

Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
Jaana Koivunen, Mira Karrasch, Noora M Scheinin, Sargo Aalto, Tero Vahlberg, Kjell Någren, Semi Helin, Matti Viitanen, Juha O Rinne. Dement Geriatr Cogn Disord 2012
14
28

Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
Thomas G Beach, Lucia I Sue, Douglas G Walker, Marwan N Sabbagh, Geidy Serrano, Brittany N Dugger, Monica Mariner, Kim Yantos, Jonette Henry-Watson, Glenn Chiarolanza,[...]. J Alzheimers Dis 2012
53
28

In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease.
Stefan J Teipel, Martin Dyrba, Patrizia A Chiesa, Fatemah Sakr, Irina Jelistratova, Simone Lista, Andrea Vergallo, Pablo Lemercier, Enrica Cavedo, Marie Odile Habert,[...]. Neurobiol Aging 2020
13
28

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
393
28

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study.
Fatemah A Sakr, Michel J Grothe, Enrica Cavedo, Irina Jelistratova, Marie-Odile Habert, Martin Dyrba, Gabriel Gonzalez-Escamilla, Hugo Bertin, Maxime Locatelli, Stephane Lehericy,[...]. Alzheimers Res Ther 2019
20
28

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Sylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, Cindee Madison, Nagehan Ayakta, Pia M Ghosh, Renaud La Joie, Samia Kate Arthur-Bentil, Jacob W Vogel, Shawn M Marks,[...]. Brain 2015
237
28

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Adam S Fleisher, Kewei Chen, Xiaofen Liu, Auttawut Roontiva, Pradeep Thiyyagura, Napatkamon Ayutyanont, Abhinay D Joshi, Christopher M Clark, Mark A Mintun, Michael J Pontecorvo,[...]. Arch Neurol 2011
242
28

Use of florbetapir-PET for imaging beta-amyloid pathology.
Christopher M Clark, Julie A Schneider, Barry J Bedell, Thomas G Beach, Warren B Bilker, Mark A Mintun, Michael J Pontecorvo, Franz Hefti, Alan P Carpenter, Matthew L Flitter,[...]. JAMA 2011
740
28

Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?
Ana M Catafau, Santiago Bullich, John P Seibyl, Henryk Barthel, Bernardino Ghetti, James Leverenz, James W Ironside, Walter J Schulz-Schaeffer, Anja Hoffmann, Osama Sabri. J Nucl Med 2016
46
28

Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
Rosebud O Roberts, Jeremiah A Aakre, Walter K Kremers, Maria Vassilaki, David S Knopman, Michelle M Mielke, Rabe Alhurani, Yonas E Geda, Mary M Machulda, Preciosa Coloma,[...]. JAMA Neurol 2018
76
28

Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study.
Byoung Seok Ye, Hee Jin Kim, Yeo Jin Kim, Na-Yeon Jung, Jin San Lee, Juyoun Lee, Young Kyoung Jang, Jin-Ju Yang, Jong-Min Lee, Jacob W Vogel,[...]. Sci Rep 2018
24
28

Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography.
Paul B Rosenberg, D F Wong, S L Edell, J S Ross, A D Joshi, J R Brašić, Y Zhou, V Raymont, A Kumar, H T Ravert,[...]. Am J Geriatr Psychiatry 2013
35
28

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
28

Beta-amyloid imaging with florbetaben.
Osama Sabri, John Seibyl, Christopher Rowe, Henryk Barthel. Clin Transl Imaging 2015
96
28

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, Oliver Peters, Peter Bartenstein, Katharina Buerger, Florian Hiemeyer, Sabine M Wittemer-Rump, John Seibyl, Cornelia Reininger,[...]. Lancet Neurol 2011
379
28

Subthreshold Amyloid Predicts Tau Deposition in Aging.
Stephanie L Leal, Samuel N Lockhart, Anne Maass, Rachel K Bell, William J Jagust. J Neurosci 2018
76
28

Subthreshold amyloid and its biological and clinical meaning: Long way ahead.
Gérard N Bischof, Heidi I L Jacobs. Neurology 2019
33
28

A practical solution to the pervasive problems of p values.
Eric-Jan Wagenmakers. Psychon Bull Rev 2007
14

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
14

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.
Niklas Mattsson, Sebastian Palmqvist, Erik Stomrud, Jacob Vogel, Oskar Hansson. JAMA Neurol 2019
82
14

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
Thomas J Montine, Creighton H Phelps, Thomas G Beach, Eileen H Bigio, Nigel J Cairns, Dennis W Dickson, Charles Duyckaerts, Matthew P Frosch, Eliezer Masliah, Suzanne S Mirra,[...]. Acta Neuropathol 2012
14

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.
Dietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, Johan Lilja, Kerstin Heurling, Aruna Chakrabarty, Azzam Ismail, Gill Farrar, Christopher Buckley, Adrian P L Smith. Acta Neuropathol 2018
30
14


Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
Stephen Salloway, Jose E Gamez, Upinder Singh, Carl H Sadowsky, Teresa Villena, Marwan N Sabbagh, Thomas G Beach, Ranjan Duara, Adam S Fleisher, Kirk A Frey,[...]. Alzheimers Dement (Amst) 2017
49
14



Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.
Erin E Franklin, Richard J Perrin, Benjamin Vincent, Michael Baxter, John C Morris, Nigel J Cairns. Alzheimers Dement 2015
29
14

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.
Hanna Cho, Jae Yong Choi, Mi Song Hwang, You Jin Kim, Hye Mi Lee, Hye Sun Lee, Jae Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo. Ann Neurol 2016
271
14

PET staging of amyloidosis using striatum.
Bernard J Hanseeuw, Rebecca A Betensky, Elizabeth C Mormino, Aaron P Schultz, Jorge Sepulcre, John A Becker, Heidi I L Jacobs, Rachel F Buckley, Molly R LaPoint, Patrizia Vannini,[...]. Alzheimers Dement 2018
68
14

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
N M Kemppainen, S Aalto, I A Wilson, K Någren, S Helin, A Brück, V Oikonen, M Kailajärvi, M Scheinin, M Viitanen,[...]. Neurology 2006
173
14

The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients.
Julia Sauerbeck, Kazunari Ishii, Chisa Hosokawa, Hayato Kaida, Franziska T Scheiwein, Kohei Hanaoka, Axel Rominger, Matthias Brendel, Peter Bartenstein, Takamichi Murakami. Ann Nucl Med 2018
5
20

Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
Thomas G Beach, Dietmar Rudolf Thal, Michelle Zanette, Adrian Smith, Christopher Buckley. J Alzheimers Dis 2016
34
14

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
Melissa E Murray, Val J Lowe, Neill R Graff-Radford, Amanda M Liesinger, Ashley Cannon, Scott A Przybelski, Bhupendra Rawal, Joseph E Parisi, Ronald C Petersen, Kejal Kantarci,[...]. Brain 2015
216
14

Bayesian inference for psychology. Part I: Theoretical advantages and practical ramifications.
Eric-Jan Wagenmakers, Maarten Marsman, Tahira Jamil, Alexander Ly, Josine Verhagen, Jonathon Love, Ravi Selker, Quentin F Gronau, Martin Šmíra, Sacha Epskamp,[...]. Psychon Bull Rev 2018
506
14

Multitracer model for staging cortical amyloid deposition using PET imaging.
Lyduine E Collij, Fiona Heeman, Gemma Salvadó, Silvia Ingala, Daniele Altomare, Arno de Wilde, Elles Konijnenberg, Marieke van Buchem, Maqsood Yaqub, Pawel Markiewicz,[...]. Neurology 2020
26
14

PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.
Gabriel Gonzalez-Escamilla, Catharina Lange, Stefan Teipel, Ralph Buchert, Michel J Grothe. Neuroimage 2017
96
14

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent Ségonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
14

[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
Dietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, Kerstin Heurling, Aruna Chakrabarty, Azzam Ismail, Adrian P L Smith, Christopher Buckley. Alzheimers Dement 2015
92
14

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Abhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, Alan P Carpenter, Danna L Jennings, Carl H Sadowsky, Lee P Adler, Karel D Kovnat, John P Seibyl, Anupa Arora,[...]. J Nucl Med 2012
249
14

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Christopher M Clark, Michael J Pontecorvo, Thomas G Beach, Barry J Bedell, R Edward Coleman, P Murali Doraiswamy, Adam S Fleisher, Eric M Reiman, Marwan N Sabbagh, Carl H Sadowsky,[...]. Lancet Neurol 2012
529
14

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman,[...]. Lancet Neurol 2014
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.